TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Juno Therapeutics Inc (NASDAQ:JUNO) Investor Investigation Over Possible Wrongdoing In Acquisition Announced

  • If you purchased shares of Juno Therapeutics Inc (NASDAQ:JUNO) and currently hold any of those NASDAQ:JUNO shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

An investigation on behalf of investors, who currently hold shares of Juno Therapeutics Inc (NASDAQ:JUNO), was announced concerning whether the takeover of Juno Therapeutics Inc. by Celgene Corporation for $87 per share is unfair to NASDAQ:JUNO stockholders. The investigation by a law firm concerns whether certain officers and directors of Juno Therapeutics Inc breached their fiducia...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: